R&D | April 20, 2026
Focus on preventive, tech-driven healthcare and digital ecosystem reforms under AB PM-JAY and ABDM
Revvity is positioning its technologies as a connected engine for discovery
The national platform brought together healthcare professionals, patient advocates, and stakeholders
The programme features headline data from pivotal Phase III trials, including PREVAIL in gMG, KOMET in NF1-PN, and CHAMPION-NMOSD, alongside real-world evidence supporting established therapies
GoodRx at a starting price of $149 per month—aligned with the lowest available discounted cash price at launch. The rollout includes nationwide pharmacy access
Veteran biopharma leader stressed that generic medicines must be viewed separately from biologics
The conference focuses on the latest advances in cancer diagnosis, treatment, and patient-centric care
The Stealth AXiS surgical navigation system was recently cleared by the US Food and Drug Administration (FDA) for cranial procedures in the United States
The initiative is a significant step toward combating antimicrobial resistance (AMR) and reducing environmental contamination from antibiotic waste
Subscribe To Our Newsletter & Stay Updated
